Background: isolated myelosarcoma of the skin in childhood is a rare manife
station of acute myeloid leukemia (AML) preceding bone marrow involvement b
y weeks to month.
Results: During the studies of AML-BFM 87/93 for the treatment of acute mye
loid leukemia an isolated myelosarcoma of the skin was diagnosed in eight p
atients aged 0.3 to 16 years. Histologically most cases were classified as
monoblastic or myelomonocytic leukemia (FAB M5, n=5; FAB M4, n=4; FAB MO, n
=1). Two infants, 3 and 6 month old remained in complete remission after be
ing treated only by surgical or by oral cytostatic therapy. Two children tr
eated according to the AML-BFM-schedule are in complete remission. Delayed
performance of diagnostic procedures and the initially mild symptoms seemed
to be the reasons for reduced treatment in the remaining cases. After firs
t relapse all patients received intensive cytostatic treatment (AML-BFM 87/
93), but all of them relapsed a second time. Three of these children died d
ue to progressive disease after 2 1/2 to 3 1/2 years. Only one patient is i
n complete remission since 6 1/2 years.
Conclusion: Suspect skin lesions should be considered as myelosarcoma prece
ding AML. Reduced treatment seems to be justified only for young toddlers w
ithout malignant bone marrow blasts. An early and intensive cytostatic trea
tment is recommended for all other children with isolated myelosarcoma of t
he skin.